OpenAlex
PricingAboutJobs
Log inGet started
Work

Long-term Survival with Ipilimumab: Experience from a National Expanded Access Program for Patients with Melanoma.

PubMed

Year: 2015
Type: article
Source: PubMed
Authors: Ivana Krajsová, Petr Arenberger, Radek Lakomý, Eugen Kubala, Ivana Březinová, Alexandr Poprach, Marek Šťastný, Jan Mužík, Bohuslav Melichar
Institutions: Charles University, Masaryk Memorial Cancer Institute, University Hospital Hradec Králové, University Hospital Ostrava, Masaryk University, University Hospital Olomouc, Palacký University Olomouc
Language: English

Topic: Cancer Immunotherapy and Biomarkers
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: ipilimumab, metastatic melanoma, refractory melanoma, expanded access program, overall survival, CTLA-4 blockade, tumor response, lactate dehydrogenase, C-reactive protein, prognostic factors, treatment response prediction
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2414868979
FWCI: 1.702
Cites:
Cited by: 30
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security